罗贝尼丁衍生物作为潜在的抗囊体药物候选物
Christian N Lotz1, Alina Krollenbrock2, Lea Imhof1
1Swiss Tropical and Public Health Institute, Kreuzstrasse 2, Allschwil, 4123, Switzerland; University of Basel, Petersplatz 1, Basel, 4051, Switzerland.
概括
新的罗贝尼丁衍生物对 Schistosoma mansoni 有前途,其中11种候选药物表现出低EC50值. 然而,体内研究显示有效性有限,这表明需要进一步改进药物治疗杆菌病.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 杆菌病对全球健康构成重大负担,由于现有的药物限制和耐药性,需要新型治疗剂.
- 罗贝尼丁衍生物,以抗疟疾活性而闻名,正在针对Schistosoma mansoni的抗胞体潜力进行探索,针对诸如血红素排毒等共享途径.
研究的目的:
- 研究罗贝尼丁衍生物作为潜在的抗杆菌药物对抗 Schistosoma mansoni 的疗效.
- 确定结构-活性关系,以增强对不同寄生虫阶段的活性.
主要方法:
- 罗贝尼丁和80种衍生物的表型查针对新变异的schistosomula和成年Schistosoma mansoni.
- 在 Schistosoma mansoni 感染的体内小鼠模型中评估化合物 (1 和 19).
主要成果:
- 十一种罗宾衍生物在体外表现出有前途的活性,具有较低的EC50值,对杆虫和成年虫均具有有前途的活性.
- 结构-活性关系分析表明,电子吸收组和特定的甲基组放置增强了抗胞体活性.
- 选择的化合物1和19在体内显示了不到20%的虫负担减轻,未能达到显著的治疗效果.
结论:
- 罗贝尼丁衍生物显示出潜在的潜力,作为一种新的抗胞体药物开发的起点.
- 进一步的结构优化至关重要,以提高治疗杆菌病的特异性和体内疗效.
相关概念视频
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
964
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
964
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
01:19Depolarizing Blockers: Pharmocokinetics
322
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
322
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
554
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
554
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
661
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
661